...
首页> 外文期刊>Propellants, Explosives, Pyrotechnics >Ageing of Australian DNAN Based Melt-Cast Insensitive Explosives
【24h】

Ageing of Australian DNAN Based Melt-Cast Insensitive Explosives

机译:澳大利亚基于DNAN的熔铸不敏感炸药的老化

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

2,4-Dinitroanisole (DNAN) is a new melt-cast matrix ingredient that replaces traditional TNT in TNT-based melt-cast explosives. Aside from sensitiveness improvements, the use of DNAN allows for the continued operation of existing melt-cast facilities (for example the Australian Munitions plants located at Mulwala and Benalla) without the need for major plant modifications. Researchers at Defence Science and Technology Group (DST Group) have developed several DNAN based formulations that have been extensively characterized. In an effort to better understand the ageing properties of these formulations, an accelerated ageing program was undertaken. Testing was conducted under two different ageing conditions; the first test condition was conducted at a constant 60 degrees C with ambient humidity and the second test condition was the A2 diurnal cycle (representative of hot dry climates). Analysis of the formulation density, sensitiveness, mechanical and thermal properties was made at three-month intervals for a period of 12 months and results compared with conventional explosives similarly aged. For all DNAN-based formulations there was negligible change in impact, friction, electrostatic discharge, and thermal testing over time. These results highlight the ability of the ARX formulations to diurnal temperature cycling and to hold favorable sensitiveness properties to various stimuli.
机译:2,4-二硝基苯甲醚(DNAN)是一种新型的熔铸基质成分,可替代基于TNT的熔铸炸药中的传统TNT。除了提高敏感性外,DNAN的使用还可以继续运行现有的熔铸设备(例如位于Mulwala和Benalla的澳大利亚弹药厂),而无需进行重大的工厂改造。国防科学技术集团(DST Group)的研究人员已经开发了几种基于DNAN的配方,这些配方已得到广泛表征。为了更好地了解这些配方的老化特性,我们进行了加速老化程序。测试是在两种不同的老化条件下进行的;第一个测试条件是在环境湿度恒定于60摄氏度的条件下进行的,第二个测试条件是A2昼夜循环(代表炎热干燥的气候)。每三个月间隔进行一次配方密度,敏感性,机械和热性能分析,为期12个月,与类似老化的常规炸药进行比较。对于所有基于DNAN的配方,冲击,摩擦,静电放电和热测试随时间的变化都可以忽略不计。这些结果突出了ARX制剂在昼夜温度循环中和保持对各种刺激的有利敏感性特性的能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号